Catalio Capital Management, LP Keros Therapeutics, Inc. Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 389,384 shares of KROS stock, worth $5.6 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
389,384
Previous 407,292
4.4%
Holding current value
$5.6 Million
Previous $6.45 Billion
38.46%
% of portfolio
0.97%
Previous 1.41%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
181Shares Held
36.7MCall Options Held
938KPut Options Held
1.39M-
Nuveen, LLC Charlotte, NC3.95MShares$56.8 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$37.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$36.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$36.2 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$28.8 Million3.97% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $371M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...